Volume 22, Number 5—May 2016
Research
Outbreak of Middle East Respiratory Syndrome at Tertiary Care Hospital, Jeddah, Saudi Arabia, 2014
Table 3
Category | No. (%) cases | Patient median age, y | No. % male patients |
---|---|---|---|
All KFGH-acquired cases |
78 (100.0) |
53 |
59 (75.6) |
Acquisition category | |||
Cohort study case-patient† | 50 (64.1) | 56 | 37 (74.0) |
Healthcare worker at KFGH | 16 (20.5) | 47 | 12 (75.0) |
Visited patient treated at KFGH | 9 (11.5) | 47 | 8 (88.9) |
Outpatient appointment at KFGH | 3 (3.8) | 59 | 2 (66.7) |
*Cases were categorized as potentially KFGH-acquired for persons who had KFGH contact before MERS onset. KFGH, King Fahd General Hospital; MERS, Middle East respiratory syndrome.
†Patients with MERS onset 2‒14 days after emergency department, inpatient, or dialysis treatment at KFGH. Includes 3 healthcare workers (1 who worked at KFGH and 2 at other hospitals) who were admitted to KFGH inpatient areas or emergency department 2‒14 days before MERS onset.
1These authors contributed equally to this article.
2Current affiliation: International Medical Center, Jeddah, Saudi Arabia.
3Current affiliation: Pfizer Inc., Collegeville, Pennsylvania, USA.
Page created: April 13, 2016
Page updated: April 13, 2016
Page reviewed: April 13, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.